Literature DB >> 10575031

Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.

Y Chai1, S L Koppenhafer, N M Bonini, H L Paulson.   

Abstract

Polyglutamine (polygln) diseases are a group of inherited neurodegenerative disorders characterized by protein misfolding and aggregation. Here, we investigate the role in polygln disease of heat shock proteins (Hsps), the major class of molecular chaperones responsible for modulating protein folding in the cell. In transfected COS7 and PC12 neural cells, we show that Hsp40 and Hsp70 chaperones localize to intranuclear aggregates formed by either mutant ataxin-3, the disease protein in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD), or an unrelated green fluorescent protein fusion protein containing expanded polygln. We further demonstrate that expression of expanded polygln protein elicits a stress response in cells as manifested by marked induction of Hsp70. Studies of SCA3/MJD disease brain confirm these findings, showing localization of Hsp40 and, less commonly, Hsp70 chaperones to intranuclear ataxin-3 aggregates. In transfected cells, overexpression of either of two Hsp40 chaperones, the DNAJ protein homologs HDJ-1 and HDJ-2, suppresses aggregation of truncated or full-length mutant ataxin-3. Finally, we extend these studies to a PC12 neural model of polygln toxicity in which we demonstrate that overexpression of HDJ-1 suppresses polygln aggregation with a parallel decrease in toxicity. These results suggest that expanded polygln protein induces a stress response and that specific molecular chaperones may aid the handling of misfolded or aggregated polygln protein in neurons. This study has therapeutic implications because it suggests that efforts to increase chaperone activity may prove beneficial in this class of diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10575031      PMCID: PMC6782415     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial?

Authors:  S S Sisodia
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

Review 2.  The Hsp70 and Hsp60 chaperone machines.

Authors:  B Bukau; A L Horwich
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

Review 3.  Glutamine repeats and neurodegenerative diseases: molecular aspects.

Authors:  M F Perutz
Journal:  Trends Biochem Sci       Date:  1999-02       Impact factor: 13.807

4.  Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease.

Authors:  V O Ona; M Li; J P Vonsattel; L J Andrews; S Q Khan; W M Chung; A S Frey; A S Menon; X J Li; P E Stieg; J Yuan; J B Penney; A B Young; J H Cha; R M Friedlander
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain.

Authors:  H L Paulson; S S Das; P B Crino; M K Perez; S C Patel; D Gotsdiner; K H Fischbeck; R N Pittman
Journal:  Ann Neurol       Date:  1997-04       Impact factor: 10.422

6.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias.

Authors:  Y Trottier; Y Lutz; G Stevanin; G Imbert; D Devys; G Cancel; F Saudou; C Weber; G David; L Tora
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

7.  Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition.

Authors:  M Kim; H S Lee; G LaForet; C McIntyre; E J Martin; P Chang; T W Kim; M Williams; P H Reddy; D Tagle; F M Boyce; L Won; A Heller; N Aronin; M DiFiglia
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

8.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

9.  Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

Authors:  J M Warrick; H L Paulson; G L Gray-Board; Q T Bui; K H Fischbeck; R N Pittman; N M Bonini
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

10.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more
  113 in total

1.  Polyglutamine disease and neuronal cell death.

Authors:  H L Paulson; N M Bonini; K A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  The role of Sis1 in the maintenance of the [RNQ+] prion.

Authors:  N Sondheimer; N Lopez; E A Craig; S Lindquist
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity.

Authors:  Peter W Faber; Cindy Voisine; Daphne C King; Emily A Bates; Anne C Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

4.  A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila.

Authors:  Barbara L Apostol; Alexsey Kazantsev; Simona Raffioni; Katalin Illes; Judit Pallos; Laszlo Bodai; Natalia Slepko; James E Bear; Frank B Gertler; Steven Hersch; David E Housman; J Lawrence Marsh; Leslie Michels Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

Review 5.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

Review 6.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

7.  The Hsp40 J-domain stimulates Hsp70 when tethered by the client to the ATPase domain.

Authors:  B Erin Horne; Tingfeng Li; Pierre Genevaux; Costa Georgopoulos; Samuel J Landry
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

Review 8.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 9.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 10.  The wobbler mouse: a neurodegeneration jigsaw puzzle.

Authors:  Séverine Boillée; Marc Peschanski; Marie-Pierre Junier
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.